Teva Pharma Industries Ltd
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Teva Pharma Industries Ltd (TEVA). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| United States [Member] | $1.54B 39.5% | $1.79B 42.8% | $1.53B 38.5% | $1.70B 41.1% |
| Europe [Member] | $1.19B 30.7% | $1.30B 31.1% | $1.34B 33.7% | $1.26B 30.5% |
| Other Activities [Member] | $579.0M 14.9% | $597.0M 14.3% | $584.0M 14.7% | $627.0M 15.1% |
| International Markets [Member] | $582.0M 15.0% | $495.0M 11.9% | $524.0M 13.2% | $550.0M 13.3% |
| Corporate Segment [Member] | – | – | – | – |
| Other Segments [Member] | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| United States [Member] | $518.0M 33.7% | $699.0M 39.1% | $507.0M 33.1% | -$76.0M -4.5% |
| Europe [Member] | $329.0M 27.6% | $364.0M 28.0% | $401.0M 29.9% | $367.0M 29.1% |
| Other Activities [Member] | – | – | – | – |
| International Markets [Member] | $97.0M 16.7% | $74.0M 14.9% | $65.0M 12.4% | $99.0M 18.0% |
| Corporate Segment [Member] | $944.0M | $1.14B | $972.0M | $391.0M |
| Other Segments [Member] | $2.0M | -$3.0M | -$16.0M | -$16.0M |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by product line
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| Sale of Goods [Member] | $3.40B 87.3% | $3.64B 87.1% | $3.39B 85.1% | $3.60B 87.0% |
| Distribution [Member] | $384.0M 9.9% | $377.0M 9.0% | $396.0M 9.9% | $433.0M 10.5% |
| Other [Member] | $76.0M 2.0% | $117.0M 2.8% | $157.0M 3.9% | $70.0M 1.7% |
| Licensing Arrangements [Member] | $36.0M 0.9% | $46.0M 1.1% | $39.0M 1.0% | $37.0M 0.9% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.